Valuation: Prince Pharmaceutical Co., Ltd.

Market Cap 1B 30.64M 27.48M 25.11M 22.92M 43.19M 2.88B 44.55M 303M 121M 1.54B 115M 113M 4.85B P/E 2024
-15x
P/E 2025 11.9x
Enterprise Value 1.27B 38.85M 34.85M 31.85M 29.07M 54.77M 3.65B 56.5M 384M 153M 1.95B 146M 143M 6.15B EV / Sales 2024
1.68x
EV / Sales 2025 1.33x
Free-Float
33.7%
Yield 2024 *
-
Yield 2025 1.61%
1 day-0.92%
1 week-1.10%
Current month-1.10%
1 month-5.79%
3 months-14.76%
6 months-13.25%
Current year-13.67%
1 week 24.7
Extreme 24.7
28.4
1 month 24.7
Extreme 24.7
28.6
Current year 24.7
Extreme 24.7
33.05
1 year 24.7
Extreme 24.7
33.8
3 years 18.5
Extreme 18.5
36.55
5 years 18.5
Extreme 18.5
75.2
10 years 18.5
Extreme 18.5
75.2
Manager TitleAgeSince
Chief Executive Officer - 2021-12-09
Director of Finance/CFO - 2008-06-01
Chief Tech/Sci/R&D Officer - 1991-01-31
Director TitleAgeSince
Chairman - -
Director/Board Member - 2023-01-17
Director/Board Member - 2023-01-17
Change 5-day change 1-year change 3-year change Capi.($)
-0.92%-1.10%-13.39%-20.21% 30.64M
-1.58%+1.36%+8.51%-13.34% 269B
-1.20%+1.66%+15.46%-4.35% 83.57B
-2.10%+2.44%-14.17%+17.94% 48.14B
-0.78%-0.68%+25.98%+557.35% 44.99B
+0.37%+7.53%+4.38%-5.79% 35.79B
-0.71%-9.02%+22.80%-2.86% 33.3B
+0.36%+2.64%-5.77%-5.89% 30.69B
+1.29%+4.31%+15.24%+14.03% 29.79B
-2.80%+1.11%+1.36%-25.81% 29.13B
Average -0.81%+0.33%+6.04%+51.11% 60.48B
Weighted average by Cap. -1.17%+1.20%+8.77%+34.99%

Financials

2024 2025
Net sales 690M 21.05M 18.88M 17.25M 15.75M 29.67M 1.98B 30.61M 208M 82.92M 1.06B 79M 77.3M 3.33B 1.06B 32.22M 28.89M 26.41M 24.1M 45.42M 3.03B 46.85M 318M 127M 1.62B 121M 118M 5.1B
Net income -53.54M -1.63M -1.46M -1.34M -1.22M -2.3M -154M -2.37M -16.14M -6.43M -81.91M -6.13M -6M -259M 96.32M 2.94M 2.63M 2.41M 2.2M 4.14M 276M 4.27M 29.03M 11.57M 147M 11.03M 10.79M 465M
Net Debt 358M 10.92M 9.79M 8.95M 8.17M 15.39M 1.03B 15.88M 108M 43.02M 548M 40.98M 40.11M 1.73B 269M 8.22M 7.37M 6.74M 6.15M 11.58M 772M 11.95M 81.19M 32.37M 412M 30.84M 30.18M 1.3B
Projected Income Statement - Annual - Prince Pharmaceutical Co., Ltd.
Logo Prince Pharmaceutical Co., Ltd.
Prince Pharmaceutical Co Ltd is a Taiwan-based Company engaged in the manufacture and sale of health food and ingredients. The Company's main business is divided into ingredients business and health food business. The ingredients business currently consists of phlegm dispelling agents, vitamin B1 derivatives, and non-steroidal anti-inflammatory drugs. The health food business is mainly engaged in the original equipment manufacturer (OEM) and original design manufacturer (ODM) of health food products, providing a series of integrated services from product formulation design, research and development to the production and packaging of various dosage forms. The Company sells its products mainly in domestic and overseas markets, including Japan and Korea.
Employees
216
Date Price Change Volume
26-11-06 NT$26.85 -0.92% 19,832
26-11-05 NT$27.10 0.00% 105,742
26-11-04 NT$27.10 -0.37% 22,041
26-11-03 NT$27.20 -4.23% 16,025
26-11-02 NT$28.40 +4.60% 17,860
  1. Stock Market
  2. Stocks
  3. 6935 Stock